Skip to main content

The influence of maintaining the correct whole blood-to-anticoagulant ratio during donation on the quality of leukoreduced whole blood.

Karger R, Lukow C, Kretschmer V

Publication: Transfusion (2011) • Vol 51 • Page 1486-92PMID: 21275999View on PubMed

Purpose

The purpose of this paper was to determine the effects of maintaining anticoagulant to blood ratio during blood collection rather than collecting blood into a container with the full amount of anticoagulant pre-added on the markers of red blood cell (RBC) quality. Analytes were evaluated on the collection day and during subsequent storage at 4 degrees C.

Conclusion

Adenosine triphosphate (ATP) levels, RBC aggregability, and factor VIII levels declined with increasing storage duration, but the effects of storage on other parameters were not discussed. Most analytes were similar between the blood collected with continuous addition of citrate phosphate dextrose adenine formula 1 (CPDA-1) and blood collected conventionally, but the aggregation amplitude was significantly higher in the conventionally collected specimens than the specimens collected with continuous addition of CPDA-1. The aggregation index (AI) was significantly higher in conventional specimens than in specimens collected with continuous addition of CPDA after 21 days of 4 degrees C storage (p0.03), but this difference decreased with additional storage up to 49 days while the difference in aggregation amplitude increased with storage duration.

Studies (1)

Purpose

The purpose of this study was to determine the effects of maintaining anticoagulant to blood ratio during blood collection rather than conventional collection on markers of RBC quality. Analytes were evaluated on the collection day and during subsequent storage at 4 degrees C. Specimens were collected from 10 blood donors of each gender and blood type (O or A D+) for each anticoagulant addition method. Male donors had hemoglobin (Hb) above 135 g/L and females had Hb above 125 g/L at their last 2 blood donations. CPDA-1 was continuously added with a roller pump to maintain the CPDA-1:blood ratio or blood was collected conventionally into bags containing CPDA-1. All blood was stored at 4 degrees C and leukoreduced 2 h after collection.

Summary of Findings

ATP levels, RBC aggregability, and factor VIII levels declined with increasing storage duration, but the effects of storage on other parameters were not discussed. On day 0, analytes were similar between the blood collected with continuous addition of CPDA-1 and blood collected conventionally, but trends toward more variability in Hb and lower AI were observed among specimens collected conventionally compared to specimens collected with continuous CPDA-1 addition. After storage of RBCs, levels of ATP, 2,3-diphosphoglycerate (2,3 DPG), potassium, glucose, lactate, free Hb, factor V, Factor VIII, fibrinogen, antithrombin (AT), and thrombin-AT complex, as well as activated partial thromboplastion time (APTT), prothrombin time (PT), thrombin time (TT), hemolysis rate, and pH were not significantly different in specimens collected with continuous addition of anticoagulant rather than collected conventionally. However, the aggregation amplitude was significantly higher and there was a trend of higher AI and lower time to 50% peak intensity (t1/2) in the conventionally collected specimens than the specimens collected with continuous addition of CPDA-1, but no differences in elongation index (EI) were observed. The difference in AI between collection groups was significant on day 21 (p0.03) but then decreased with additional storage up to 49 days while the difference in amplitude increased with storage duration.

  • Biospecimens

    FluidBlood
    CellRed Blood Cells
  • Preservation Types

    Other Preservative
  • Diagnoses

    Normal
  • Platforms

    CarbohydrateClinical chemistry/auto analyzer
    Small moleculeClinical chemistry/auto analyzer
    Small moleculeEnzyme assay
    Electrolyte/MetalFlame emission photometry
    GlycoproteinClinical chemistry/auto analyzer
    ProteinHematology/ auto analyzer
    ProteinEnzyme assay
    ProteinClinical chemistry/auto analyzer
    PeptideHematology/ auto analyzer
    MorphologyHematology/ auto analyzer
    Cell count/volumeFlow cytometry
    Cell count/volumeHematology/ auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionAnticoagulant
    Citrate phosphate dextrose adenine 1
    Continuously added
    In tube/bag
    StorageStorage duration
    0 days
    21 days
    35 days
    42 days
    49 days
    7 days